The concern of generic rivalry has repeatedly loomed over copyright’s famous drug, Viagra, triggering questions about the outlook of similar medicinal holdings. While initial times saw substantial gains, the patent expiration has created the path for less expensive alternatives, possibly diminishing profitability and presenting a significant dang